Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2023 07:00 ET | Source: COMPASS Pathways

COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business Highlights

Highlights: COMP360 Phase 3 pivotal program ongoing with expanding European clinical sitesSecured up to $285 million private placement financing with $125 million upfrontCash position at September 30,...
October 26, 2023 08:00 ET | Source: COMPASS Pathways

COMPASS Pathways announces CFO transition

LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS” or the “company”), a biotechnology company dedicated to accelerating patient access to evidence-based...
October 24, 2023 16:01 ET | Source: COMPASS Pathways

COMPASS Pathways plc to Announce Third Quarter 2023 Financial Results on November 2, 2023

LONDON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health,...
September 18, 2023 16:31 ET | Source: COMPASS Pathways

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...
September 06, 2023 04:00 ET | Source: COMPASS Pathways

COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

LONDON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...
August 29, 2023 16:30 ET | Source: COMPASS Pathways

COMPASS Pathways to participate in upcoming September investor conferences

LONDON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health,...
August 16, 2023 08:58 ET | Source: COMPASS Pathways

COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million tied to exercise of warrants Net proceeds...
August 03, 2023 07:00 ET | Source: COMPASS Pathways

COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights

LONDON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Highlights: COMP360 Phase 3 pivotal program ongoing and on trackCPT® III code for in-person psychedelic therapy support accepted by the American Medical...
July 31, 2023 08:32 ET | Source: COMPASS Pathways

COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

LONDON, July 31, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health,...
July 25, 2023 04:00 ET | Source: COMPASS Pathways

First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine

LONDON, July 25, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...